I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibitionCongying Gao(Weifang Medical University), Liuya Wei(Weifang Medical University)Frontiers in PharmacologyApril 12, 202310.3389/fphar.2023.1183052Cited by 8SaveCiteExport RISWatch citationsRelated PapersThe Histone Deacetylase Inhibitor I1 Induces Differentiation of Acute Leukemia Cells With MLL Gene Rearrangements via Epigenetic Modification|Frontiers in Pharmacology|2022|13